The pharmaceutical industry is witnessing a significant shift in glucose care with the introduction of GLP-1 transdermal devices. These innovative methods offer a potentially easy choice to injections for individuals living with diabetes mellitus type 2. By circumventing the requirement for frequent injections, GLP-1 adhesives promise to boost i… Read More